NKGen Biotech, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
NKGen Biotech, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2021 to Q2 2024.
  • NKGen Biotech, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$16.1M, a 105% decline year-over-year.
  • NKGen Biotech, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$88.3M, a 92.3% decline year-over-year.
  • NKGen Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$83M, a 210% decline from 2022.
  • NKGen Biotech, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$26.8M, a 2601% decline from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$88.3M -$16.1M -$8.24M -105% Apr 1, 2024 Jun 30, 2024 10-Q 2024-09-12
Q1 2024 -$80M -$5.38M +$2.94M +35.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 -$83M -$33.6M -$10.6M -46% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 -$72.4M -$33.2M -$26.5M -396% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$45.9M -$7.85M -$8.81M -921% Apr 1, 2023 Jun 30, 2023 10-Q 2024-09-12
Q1 2023 -$37.1M -$8.32M -$10.3M -515% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
Q4 2022 -$26.8M -$23M -$21.7M -1619% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 -$5.07M -$6.69M -$11.4M -243% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $6.31M $956K +$5.27M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $1.05M $2M +$2.04M Jan 1, 2022 Mar 31, 2022 10-Q 2023-08-14
Q4 2021 -$991K -$1.34M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 $4.69M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$4.31M Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$35.7K Jan 28, 2021 Mar 31, 2021 10-Q 2022-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.